China 314771-76-1 Factory

abide by the contract, conforms on the market requirement, joins from the market competition by its good quality likewise as provides more comprehensive and superb support for customers to let them become large winner. The pursue of the company, is definitely the clients' pleasure for 314771-76-1,CAS NO 314771-76-1,Afatinib intermediate,Afatinib advance intermediate,(S)-N4-(3-chloro-4-fluorophenyl)-, We warmly welcome buddies from all walks of everyday living to hunt mutual cooperation and build a more brilliant and splendid tomorrow.
314771-76-1, Our company always committed to meet your quality demand, price points and sales target. Warmly welcome you open the boundaries of communication. It is our great pleasure to service you if you want a trusted supplier and value information.

Hot Products

  • Cefixime

    Cefixime

    Product Name:Cefixime
    Molecular Formula:C16H15N5O7S2
    Molecular Weight;453.45
    CAS Registry Number;79350-37-1
  • 1-Methyl-3-phenylpiperazine

    1-Methyl-3-phenylpiperazine

    Product Name:1-Methyl-3-phenylpiperazine
    Molecular Formula:C11H16N2
    Molecular Weight:176.26
    CAS Registry Number:5271-27-2
  • LY 2784544

    LY 2784544

    Product Name:LY 2784544
    Molecular Formula:C23H25ClFN7O
    Molecular Weight;469.94
    CAS Registry Number;1229236-86-5
  • trimethylpropylammonium bromide

    trimethylpropylammonium bromide

    Product Name:trimethylpropylammonium bromide
    Molecular Formula:C6H16BrN
    Molecular Weight:182.10194
    CAS Registry Number:2650-50-2
  • (3,4-Dimethoxyphenyl)acetic acid

    (3,4-Dimethoxyphenyl)acetic acid

    Product Name:(3,4-Dimethoxyphenyl)acetic acid
    Molecular Formula:C10H12O4
    Molecular Weight:196.2
    CAS Registry Number:93-40-3
  • Tadalafil

    Tadalafil

    Product Name:Tadalafil
    Molecular Formula:C22H19N3O4
    Molecular Weight;389.4
    CAS Registry Number;171596-29-5

Send Inquiry

X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept